ID   SRBP1_RAT               Reviewed;        1134 AA.
AC   P56720; Q99PI6; Q99PI7;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 3.
DT   02-OCT-2024, entry version 200.
DE   RecName: Full=Sterol regulatory element-binding protein 1 {ECO:0000303|PubMed:11309661};
DE            Short=SREBP-1 {ECO:0000303|PubMed:11309661};
DE   AltName: Full=Adipocyte determination- and differentiation-dependent factor 1 {ECO:0000303|PubMed:11309661};
DE            Short=ADD1 {ECO:0000303|PubMed:11309661};
DE   AltName: Full=Sterol regulatory element-binding transcription factor 1 {ECO:0000303|PubMed:11309661};
DE   Contains:
DE     RecName: Full=Processed sterol regulatory element-binding protein 1 {ECO:0000305};
DE     AltName: Full=Transcription factor SREBF1 {ECO:0000305};
GN   Name=Srebf1 {ECO:0000312|RGD:69423};
GN   Synonyms=Srebp1 {ECO:0000303|PubMed:11309661};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1046 (ISOFORM SREBP-1C), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Adipocyte;
RX   PubMed=8336713; DOI=10.1128/mcb.13.8.4753-4759.1993;
RA   Tontonoz P., Kim J.B., Graves R.A., Spiegelman B.M.;
RT   "ADD1: a novel helix-loop-helix transcription factor associated with
RT   adipocyte determination and differentiation.";
RL   Mol. Cell. Biol. 13:4753-4759(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1012 (ISOFORM SREBP-1C), AND VARIANT
RP   MET-779.
RC   STRAIN=BN-Lx/Cub, and SHR/Ola;
RX   PubMed=11309661; DOI=10.1007/s003350010273;
RA   Pravenec M., Jansa P., Kostka V., Zidek V., Kren V., Forejt J., Kurtz T.W.;
RT   "Identification of a mutation in ADD1/SREBP-1 in the spontaneously
RT   hypertensive rat.";
RL   Mamm. Genome 12:295-298(2001).
RN   [4]
RP   DNA-BINDING.
RX   PubMed=7739539; DOI=10.1128/mcb.15.5.2582;
RA   Kim J.B., Spotts G.D., Halvorsen Y.D., Shih H.M., Ellenberger T.,
RA   Towle H.C., Spiegelman B.M.;
RT   "Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino
RT   acid in the basic helix-loop-helix domain.";
RL   Mol. Cell. Biol. 15:2582-2588(1995).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-448, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: [Sterol regulatory element-binding protein 1]: Precursor of
CC       the transcription factor form (Processed sterol regulatory element-
CC       binding protein 1), which is embedded in the endoplasmic reticulum
CC       membrane (By similarity). Low sterol concentrations promote processing
CC       of this form, releasing the transcription factor form that translocates
CC       into the nucleus and activates transcription of genes involved in
CC       cholesterol biosynthesis and lipid homeostasis (By similarity).
CC       {ECO:0000250|UniProtKB:P36956, ECO:0000250|UniProtKB:Q9WTN3}.
CC   -!- FUNCTION: [Processed sterol regulatory element-binding protein 1]: Key
CC       transcription factor that regulates expression of genes involved in
CC       cholesterol biosynthesis and lipid homeostasis (By similarity). Binds
CC       to the sterol regulatory element 1 (SRE-1) (5'-ATCACCCCAC-3')
CC       (PubMed:7739539). Has dual sequence specificity binding to both an E-
CC       box motif (5'-ATCACGTGA-3') and to SRE-1 (5'-ATCACCCCAC-3') (By
CC       similarity). Regulates the promoters of genes involved in cholesterol
CC       biosynthesis and the LDL receptor (LDLR) pathway of sterol regulation
CC       (By similarity). {ECO:0000250|UniProtKB:P36956,
CC       ECO:0000269|PubMed:7739539}.
CC   -!- FUNCTION: [Isoform SREBP-1A]: Isoform expressed only in select tissues,
CC       which has higher transcriptional activity compared to SREBP-1C (By
CC       similarity). Able to stimulate both lipogenic and cholesterogenic gene
CC       expression (By similarity). Has a role in the nutritional regulation of
CC       fatty acids and triglycerides in lipogenic organs such as the liver.
CC       Required for innate immune response in macrophages by regulating lipid
CC       metabolism (By similarity). {ECO:0000250|UniProtKB:P36956,
CC       ECO:0000250|UniProtKB:Q9WTN3}.
CC   -!- FUNCTION: [Isoform SREBP-1C]: Predominant isoform expressed in most
CC       tissues, which has weaker transcriptional activity compared to isoform
CC       SREBP-1A (By similarity). Primarily controls expression of lipogenic
CC       gene (By similarity). Strongly activates global lipid synthesis in
CC       rapidly growing cells (By similarity). {ECO:0000250|UniProtKB:P36956,
CC       ECO:0000250|UniProtKB:Q9WTN3}.
CC   -!- ACTIVITY REGULATION: Activation by cleavage is down-regulated upon
CC       activation of SIRT3-dependent PRKAA1/AMPK-alpha signaling cascade which
CC       leads to inhibition of ATP-consuming lipogenesis to restore cellular
CC       energy balance. {ECO:0000250|UniProtKB:Q9WTN3}.
CC   -!- SUBUNIT: [Sterol regulatory element-binding protein 1]: Forms a tight
CC       complex with SCAP, the SCAP-SREBP complex, in the endoplasmic reticulum
CC       membrane. {ECO:0000250|UniProtKB:P36956}.
CC   -!- SUBUNIT: [Processed sterol regulatory element-binding protein 1]:
CC       Efficient DNA binding of the soluble transcription factor fragment
CC       requires dimerization with another bHLH protein (By similarity).
CC       Interacts with CEBPA, the interaction produces a transcriptional
CC       synergy. Interacts with LMNA (By similarity).
CC       {ECO:0000250|UniProtKB:P36956, ECO:0000250|UniProtKB:Q9WTN3}.
CC   -!- SUBCELLULAR LOCATION: [Sterol regulatory element-binding protein 1]:
CC       Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:P36956}; Multi-
CC       pass membrane protein {ECO:0000255}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q9WTN3}; Multi-pass membrane protein
CC       {ECO:0000255}. Cytoplasmic vesicle, COPII-coated vesicle membrane
CC       {ECO:0000250|UniProtKB:Q9WTN3}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=At high sterol concentrations, the SCAP-SREBP is
CC       retained in the endoplasmic reticulum. Low sterol concentrations
CC       promote recruitment into COPII-coated vesicles and transport of the
CC       SCAP-SREBP to the Golgi, where it is processed.
CC       {ECO:0000250|UniProtKB:Q9WTN3}.
CC   -!- SUBCELLULAR LOCATION: [Processed sterol regulatory element-binding
CC       protein 1]: Nucleus {ECO:0000250|UniProtKB:P36956}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=SREBP-1A;
CC         IsoId=P56720-2; Sequence=Displayed;
CC       Name=SREBP-1C; Synonyms=ADD1;
CC         IsoId=P56720-1; Sequence=VSP_030860;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in brown adipose tissue.
CC       {ECO:0000269|PubMed:8336713}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000250|UniProtKB:P36956}.
CC   -!- PTM: [Sterol regulatory element-binding protein 1]: Processed in the
CC       Golgi apparatus, releasing the protein from the membrane. At low
CC       cholesterol the SCAP-SREBP complex is recruited into COPII vesicles for
CC       export from the endoplasmic reticulum. In the Golgi, complex SREBPs are
CC       cleaved sequentially by site-1 (MBTPS1, S1P) and site-2 (MBTPS2, S2P)
CC       proteases. The first cleavage by site-1 protease occurs within the
CC       luminal loop, the second cleavage by site-2 protease occurs within the
CC       first transmembrane domain, releasing the transcription factor from the
CC       Golgi membrane. {ECO:0000250|UniProtKB:P36956}.
CC   -!- PTM: Phosphorylated by AMPK, leading to suppress protein processing and
CC       nuclear translocation, and repress target gene expression.
CC       Phosphorylation at Ser-395 by SIK1 represses activity possibly by
CC       inhibiting DNA-binding. {ECO:0000250|UniProtKB:Q9WTN3}.
CC   -!- PTM: [Processed sterol regulatory element-binding protein 1]:
CC       Ubiquitinated; the nuclear form has a rapid turnover and is rapidly
CC       ubiquitinated and degraded by the proteasome in the nucleus.
CC       {ECO:0000250|UniProtKB:P36956}.
CC   -!- SIMILARITY: Belongs to the SREBP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=L16995; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03073826; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03076830; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; L16995; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF286469; AAG28733.2; -; mRNA.
DR   EMBL; AF286470; AAG28734.2; ALT_TERM; mRNA.
DR   RefSeq; NP_001263636.1; NM_001276707.1. [P56720-2]
DR   AlphaFoldDB; P56720; -.
DR   SMR; P56720; -.
DR   BioGRID; 249376; 10.
DR   STRING; 10116.ENSRNOP00000050057; -.
DR   iPTMnet; P56720; -.
DR   PhosphoSitePlus; P56720; -.
DR   PaxDb; 10116-ENSRNOP00000050057; -.
DR   Ensembl; ENSRNOT00000004753.6; ENSRNOP00000004753.6; ENSRNOG00000003463.9. [P56720-1]
DR   Ensembl; ENSRNOT00000047053.7; ENSRNOP00000050057.3; ENSRNOG00000003463.9. [P56720-2]
DR   GeneID; 78968; -.
DR   KEGG; rno:78968; -.
DR   UCSC; RGD:69423; rat. [P56720-2]
DR   AGR; RGD:69423; -.
DR   CTD; 6720; -.
DR   RGD; 69423; Srebf1.
DR   eggNOG; KOG2588; Eukaryota.
DR   GeneTree; ENSGT00940000159156; -.
DR   InParanoid; P56720; -.
DR   OMA; QLCQHIP; -.
DR   OrthoDB; 3668492at2759; -.
DR   PhylomeDB; P56720; -.
DR   TreeFam; TF313894; -.
DR   Reactome; R-RNO-1655829; Regulation of cholesterol biosynthesis by SREBP (SREBF).
DR   Reactome; R-RNO-191273; Cholesterol biosynthesis.
DR   PRO; PR:P56720; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003463; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:HGNC-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0004879; F:nuclear receptor activity; ISO:RGD.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0032810; F:sterol response element binding; ISS:HGNC-UCL.
DR   GO; GO:0001221; F:transcription coregulator binding; ISO:RGD.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEP:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0009267; P:cellular response to starvation; IDA:HGNC-UCL.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; ISO:RGD.
DR   GO; GO:0008203; P:cholesterol metabolic process; IMP:RGD.
DR   GO; GO:0007623; P:circadian rhythm; ISO:RGD.
DR   GO; GO:0045444; P:fat cell differentiation; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0030073; P:insulin secretion; ISO:RGD.
DR   GO; GO:0008610; P:lipid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0030324; P:lung development; IEP:RGD.
DR   GO; GO:0042789; P:mRNA transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0090209; P:negative regulation of triglyceride metabolic process; ISO:RGD.
DR   GO; GO:0045542; P:positive regulation of cholesterol biosynthetic process; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:RGD.
DR   GO; GO:0045089; P:positive regulation of innate immune response; ISO:RGD.
DR   GO; GO:0046889; P:positive regulation of lipid biosynthetic process; ISO:RGD.
DR   GO; GO:1902895; P:positive regulation of miRNA transcription; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0019217; P:regulation of fatty acid metabolic process; ISO:RGD.
DR   GO; GO:0003062; P:regulation of heart rate by chemical signal; ISO:RGD.
DR   GO; GO:0050796; P:regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0010883; P:regulation of lipid storage; IEP:RGD.
DR   GO; GO:1901524; P:regulation of mitophagy; ISO:RGD.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:RGD.
DR   GO; GO:1903214; P:regulation of protein targeting to mitochondrion; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0051591; P:response to cAMP; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0070542; P:response to fatty acid; IEP:RGD.
DR   GO; GO:0032094; P:response to food; IEP:RGD.
DR   GO; GO:0009750; P:response to fructose; IEP:RGD.
DR   GO; GO:0033762; P:response to glucagon; IEP:RGD.
DR   GO; GO:0009749; P:response to glucose; ISO:RGD.
DR   GO; GO:0032868; P:response to insulin; TAS:BHF-UCL.
DR   GO; GO:0033993; P:response to lipid; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0043434; P:response to peptide hormone; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0032526; P:response to retinoic acid; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0032933; P:SREBP signaling pathway; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd18921; bHLHzip_SREBP1; 1.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   PANTHER; PTHR46062; STEROL REGULATORY ELEMENT-BINDING PROTEIN; 1.
DR   PANTHER; PTHR46062:SF2; STEROL REGULATORY ELEMENT-BINDING PROTEIN 1; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Cholesterol metabolism;
KW   Cytoplasmic vesicle; DNA-binding; Endoplasmic reticulum; Golgi apparatus;
KW   Lipid metabolism; Membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   Steroid metabolism; Sterol metabolism; Transcription;
KW   Transcription regulation; Transmembrane; Transmembrane helix;
KW   Ubl conjugation.
FT   CHAIN           1..1134
FT                   /note="Sterol regulatory element-binding protein 1"
FT                   /id="PRO_0000127450"
FT   CHAIN           1..480
FT                   /note="Processed sterol regulatory element-binding protein
FT                   1"
FT                   /evidence="ECO:0000250|UniProtKB:Q12772"
FT                   /id="PRO_0000314031"
FT   TOPO_DOM        1..481
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        482..502
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        503..536
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        537..557
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        558..1134
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          317..367
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   REGION          1..60
FT                   /note="Transcriptional activation (acidic)"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   REGION          46..102
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          116..221
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          227..487
FT                   /note="Interaction with LMNA"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTN3"
FT   REGION          367..388
FT                   /note="Leucine-zipper"
FT   REGION          415..468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           27..35
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   COMPBIAS        60..80
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        129..157
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        166..221
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        422..453
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            451..452
FT                   /note="Cleavage; by caspase-3 and caspase-7"
FT                   /evidence="ECO:0000250|UniProtKB:Q12772"
FT   SITE            480..481
FT                   /note="Cleavage; by MBTPS2"
FT                   /evidence="ECO:0000250|UniProtKB:Q12772"
FT   SITE            519..520
FT                   /note="Cleavage; by MBTPS1"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   MOD_RES         97
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   MOD_RES         331
FT                   /note="Phosphoserine; by SIK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTN3"
FT   MOD_RES         332
FT                   /note="Phosphoserine; by SIK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTN3"
FT   MOD_RES         389
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTN3"
FT   MOD_RES         395
FT                   /note="Phosphoserine; by SIK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTN3"
FT   MOD_RES         448
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1047
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P36956"
FT   VAR_SEQ         1..29
FT                   /note="MDELPFGEAALEQALAEVCEMDAALLTDI -> MDCTF (in isoform
FT                   SREBP-1C)"
FT                   /evidence="ECO:0000303|PubMed:11309661,
FT                   ECO:0000303|PubMed:8336713"
FT                   /id="VSP_030860"
FT   VARIANT         779
FT                   /note="V -> M (in spontaneously hypertensive rats)"
FT                   /evidence="ECO:0000269|PubMed:11309661"
FT   CONFLICT        267
FT                   /note="G -> A (in Ref. 1; L16995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        475
FT                   /note="R -> P (in Ref. 1; L16995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        817
FT                   /note="D -> H (in Ref. 1; L16995)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1134 AA;  120521 MW;  1D31A9AD3C36AB29 CRC64;
     MDELPFGEAA LEQALAEVCE MDAALLTDIE DMLQLINNQD SDFPGLFDAP YAGGETGDTG
     PSSPGASSPE SFSSPASLGS SLEAFLGGPK VTPAPLSPPP SAPTAVKMYP SVPPFSPGPG
     IKEEPVPLTI LQPPAPQPSP GTLLPPSFPP PPVQLSPAPV LGYSSLPSGF SGTLPGNTQQ
     TPSSLPLGST PGISPTPLHT QVQSSAAQQP PPASAAPRMS TVASQIQQVP VVLQPHFIKA
     DSLLLTAVKT DTGATMKTAG INTLAPGTAV QAGPLQTLVS GGTILATVPL VVDTDKLPIH
     RLAAGGKALG SAQSRGEKRT AHNAIEKRYR SSINDKIVEL KDLVVGTEAK LNKSAVLRKA
     IDYIRFLQHS NQKLKQENLT LRSAHKSKSL KDLVSACGSG GGTDVSMEGM KPEVVETLTP
     PPSDAGSPSQ SSPLSLGSRG SSSGGSDSEP DSPAFEDNQV KAQRLPSHSR GMLDRSRLAL
     CVLVFLCLTC NPLASLFGWG ILTPSDASGV HRSSGRSMLE AESRDGSNWT QWLLPPLVWL
     ANGLLVLACL ALLFVYGEPV TRPHSGPAVH FWRHRKQADL DLARGDFAQA AQQLWLALQA
     LGRPLPTSNL DLACSLLWNL VRHLLQRLWV GRWLAGQAGG LQRDYRLRKD ARASARDAAV
     VYHKLHQLHA MGKYTGGHLV ASNLALSALN LAECAGDAIS MATLAEIYVA AALRVKTSLP
     RALHFLTRFF LSSARQACLA QSGAVPLAMQ WLCHPVGHRF FVDGDWAVHG APQESLYSVA
     GNPVDPLAQV TRLFCEHLLE RALNCIAQPS PGAADGDREF SDALGYLQLL NSCSDAVGAP
     ACSFSVSSSM ATTTGTDPVA KWWASLTAVV IHWLRRDEEA AERLYPLVEH IPQVLQETER
     PLPRAALYSF KAARALLDHR KVESSPASLA ICEKASGYLR DSLASTSTAS SIDKAMQLLL
     CDLLLVARTS LWRRQQSAAS AQGAHGTSNG PQASALELRG FQHDLSSLRR LAQSFRPAMR
     RVFLHEATAR LMAGASPART HQLLDRSLRR RAGSSGKGGA AAELEPRPTW REHTEALLLA
     SCYLPPAFLS APGQRVSMLA EAARTVEKLG DHRLLLDCQQ MLLRLGGGTT VTSS
//
